The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females

@inproceedings{Hermans2012TheAD,
  title={The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females},
  author={Michel P Hermans and Sylvie A. Ahn and Michel F. Rousseau},
  booktitle={Lipids in Health and Disease},
  year={2012}
}
Atherogenic dyslipidemia (AD), defined as low HDL-C plus elevated triglycerides (TG), comorbid to T2DM, increases cardiometabolic risk for CAD even when LDL-C is at target. In T2DM males, AD was shown to correlate with β-cell function loss, yet it is not established whether this applies across gender. To establish the prevalence and severity of AD in T2DM females, and to determine how it relates to cardiometabolic phenotype, glucose homeostasis, micro- and macrovascular complications, and 10… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 31 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 48 references

Residual vascular risk in T2DM: the next frontier

  • MP Hermans, SA Ahn, MF Rousseau
  • Edited by Mark B. Zimering. Rijeka (Croatia…
  • 2011
Highly Influential
6 Excerpts

Reducing residual vascular risk in patients with atherogenic dyslipidaemia: where do we go from here

  • MP Hermans, JC Fruchart
  • Clinical Lipidology
  • 2010
Highly Influential
5 Excerpts

Micro- and macrovascular risk and complications in T2DM males with obstructive sleep apnoea

  • MP Hermans, SA Ahn, MF Rousseau
  • J Clin Metab Diab
  • 2011
2 Excerpts

Effects of combination lipid therapy in type 2 diabetes mellitus

  • Group ACCORD Study, HN Ginsberg, +15 authors RP Byington
  • N Engl J Med
  • 2010
2 Excerpts

Similar Papers

Loading similar papers…